Supplementary information
From the following article:
Ronald S. Veazey, Per Johan Klasse, Susan M. Schader, Qinxue Hu, Thomas J. Ketas, Min Lu, Preston A. Marx, Jason Dufour, Richard J. Colonno, Robin J. Shattock, Martin S. Springer and John P. Moore
Nature 438, 99-102 (3 November 2005)
doi:10.1038/nature04055
Supplementary Notes*
This section contains details on synergy between entry inhibitors in vitro, vaginal challenges with SHIV-162P4 and plasma viral load in SHIV-162P3-infected animals.
* This Supplementary Information was substituted for an earlier version on 14/11/05. The replacement is identical, except that it contains a detailed directive for reagent requests on page 4.
Supplementary Figure 1
Challenge studies with SHIV-162P4, partial protection by CMPD167 and C52L.
Supplementary Figure 2
Plasma VL in SHIV-162P3-infected animals.
DOWNLOAD BROWSER PLUGINS AND OTHER APPLICATIONS
Movie files
PDF douments
Text documents
PostScript documents
Flash movies
Audio files
- Apple iTunes (PC or Mac)
- QuickTime Player (PC or Mac)
- Realplayer (PC or Mac)
- Windows Media player (PC only)
